Details
Stereochemistry | ACHIRAL |
Molecular Formula | C7H16N2O.ClH |
Molecular Weight | 180.676 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCCCCNCC(N)=O
InChI
InChIKey=DNSCECUSJKDSKP-UHFFFAOYSA-N
InChI=1S/C7H16N2O.ClH/c1-2-3-4-5-9-6-7(8)10;/h9H,2-6H2,1H3,(H2,8,10);1H
Milacemide, a prodrug for glycine, is an inhibitor of the B form of monoamine oxidase. This drug could enhance dopaminergic activity in the brain and could be used as therapy for Parkinson's disease. Milacemide participated in clinical trials as a treatment for senile dementia of the Alzheimer type (SDAT). However, results have shown the drug was not an effective treatment in enhancing cognition in SDAT patients. In addition, milacemide has been tested for antiepileptic efficacy; however, this study was discontinued.
CNS Activity
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
The novel neuropsychotropic agent milacemide is a specific enzyme-activated inhibitor of brain monoamine oxidase B. | 1989 Oct |
|
Milacemide therapy for Parkinson's disease. | 1993 |
|
Safinamide for the treatment of Parkinson's disease, epilepsy and restless legs syndrome. | 2007 Jul |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1634705
1200 mg/day milacemide treatment for 1 month (113 patients received milacemide, and 115 patients received placebo
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C264
Created by
admin on Fri Dec 15 16:06:46 GMT 2023 , Edited by admin on Fri Dec 15 16:06:46 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
76990-85-7
Created by
admin on Fri Dec 15 16:06:46 GMT 2023 , Edited by admin on Fri Dec 15 16:06:46 GMT 2023
|
PRIMARY | |||
|
6XK4G40F6W
Created by
admin on Fri Dec 15 16:06:46 GMT 2023 , Edited by admin on Fri Dec 15 16:06:46 GMT 2023
|
PRIMARY | |||
|
CHEMBL75838
Created by
admin on Fri Dec 15 16:06:46 GMT 2023 , Edited by admin on Fri Dec 15 16:06:46 GMT 2023
|
PRIMARY | |||
|
DTXSID70227787
Created by
admin on Fri Dec 15 16:06:46 GMT 2023 , Edited by admin on Fri Dec 15 16:06:46 GMT 2023
|
PRIMARY | |||
|
C81470
Created by
admin on Fri Dec 15 16:06:46 GMT 2023 , Edited by admin on Fri Dec 15 16:06:46 GMT 2023
|
PRIMARY | |||
|
X-85
Created by
admin on Fri Dec 15 16:06:46 GMT 2023 , Edited by admin on Fri Dec 15 16:06:46 GMT 2023
|
PRIMARY | |||
|
53568
Created by
admin on Fri Dec 15 16:06:46 GMT 2023 , Edited by admin on Fri Dec 15 16:06:46 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD